Clinical trial
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn®…
NCT00489255 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00489255 |
|---|---|
| Title | Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment |
| Official title | A Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Subjects With Parkinson's Disease Suffering From… |
| Lead sponsor | Ipsen, Industry |
| Collaborators | INC Research Limited Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Tigan®, Placebo |
| Enrollment | 117 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | Mar 1, 2012 |
| First posted | Jun 21, 2007 |
| Last update posted | Jan 30, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: